Ratings M1 Kliniken AG

Equities

M12

DE000A0STSQ8

Market Closed - Xetra Other stock markets 11:36:23 2024-05-10 am EDT			5-day change	1st Jan Change
16 ^EUR	-3.03%		+1.59%	+42.86%

Feb. 05	M1 Kliniken Mull Uplisting to Frankfurt Bourse's Prime Standard; Co-CEOs Buy 1.5 Million Shares	MT
2023	M1 Kliniken Takes Ownership of Dutch Online Pharmacy	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
The company sustains low margins.
With an expected P/E ratio at 40 and 27.83 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The company is highly valued given the cash flows generated by its activity.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

	1st Jan change	Capi.	ESG Refinitiv
M1 KLINIKEN AG	+42.86%	316M	-
AIER EYE HOSPITAL GROUP CO., LTD.	-18.90%	16.51B	B+
BANGKOK DUSIT MEDICAL SERVICES	+4.50%	12.53B	B
IHH HEALTHCARE	+4.81%	11.74B	B+
APOLLO HOSPITALS ENTERPRISE LIMITED	+2.43%	10.06B	B+
RAMSAY HEALTH CARE LIMITED	-4.75%	7.57B	A-
MOUWASAT MEDICAL SERVICES COMPANY	+21.11%	7.22B	D
THE ENSIGN GROUP, INC.	+5.46%	6.68B	B-
GLOBAL HEALTH LIMITED	+45.72%	4.54B	-
DALLAH HEALTHCARE COMPANY	-3.49%	4.32B	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes